Compare Suven Life Sciences with Dishman Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE SCIENCES vs DISHMAN PHARMA - Comparison Results

DISHMAN PHARMA 
   Change

Dishman Pharmaceuticals is involved in the manufacture of APIs (active pharmaceutical ingredients), intermediates, quaternary compounds and fine chemicals. Besides this, the company is a significant player in the CRAMS (Contract Research and Manufact... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE SCIENCES DISHMAN PHARMA SUVEN LIFE SCIENCES/
DISHMAN PHARMA
 
P/E (TTM) x -79.8 25.1 - View Chart
P/BV x 1.3 3.3 37.4% View Chart
Dividend Yield % 1.8 0.7 276.0%  

Financials

 SUVEN LIFE SCIENCES   DISHMAN PHARMA
EQUITY SHARE DATA
    SUVEN LIFE SCIENCES
Mar-19
DISHMAN PHARMA
Mar-16
SUVEN LIFE SCIENCES/
DISHMAN PHARMA
5-Yr Chart
Click to enlarge
High Rs338374 90.2%   
Low Rs169129 131.4%   
Sales per share (Unadj.) Rs52.1197.8 26.4%  
Earnings per share (Unadj.) Rs6.821.2 32.2%  
Cash flow per share (Unadj.) Rs8.634.7 24.7%  
Dividends per share (Unadj.) Rs1.502.00 75.0%  
Dividend yield (eoy) %0.60.8 74.4%  
Book value per share (Unadj.) Rs65.3179.9 36.3%  
Shares outstanding (eoy) m127.2880.69 157.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.91.3 382.3%   
Avg P/E ratio x37.111.9 312.8%  
P/CF ratio (eoy) x29.67.2 408.2%  
Price / Book Value ratio x3.91.4 277.6%  
Dividend payout %22.09.4 232.8%   
Avg Mkt Cap Rs m32,27220,306 158.9%   
No. of employees `0001.10.8 130.5%   
Total wages/salary Rs m6615,355 12.3%   
Avg. sales/employee Rs Th6,132.219,252.7 31.9%   
Avg. wages/employee Rs Th611.16,459.5 9.5%   
Avg. net profit/employee Rs Th803.52,064.1 38.9%   
INCOME DATA
Net Sales Rs m6,63515,961 41.6%  
Other income Rs m242265 91.3%   
Total revenues Rs m6,87716,226 42.4%   
Gross profit Rs m1,6044,103 39.1%  
Depreciation Rs m2211,091 20.3%   
Interest Rs m38944 4.0%   
Profit before tax Rs m1,5872,334 68.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m01 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m718624 115.1%   
Profit after tax Rs m8691,711 50.8%  
Gross profit margin %24.225.7 94.0%  
Effective tax rate %45.226.7 169.3%   
Net profit margin %13.110.7 122.2%  
BALANCE SHEET DATA
Current assets Rs m6,23211,018 56.6%   
Current liabilities Rs m1,4909,517 15.7%   
Net working cap to sales %71.59.4 760.0%  
Current ratio x4.21.2 361.3%  
Inventory Days Days86110 78.2%  
Debtors Days Days8335 237.1%  
Net fixed assets Rs m4,04316,304 24.8%   
Share capital Rs m127161 78.9%   
"Free" reserves Rs m8,18312,907 63.4%   
Net worth Rs m8,31014,516 57.2%   
Long term debt Rs m184,189 0.4%   
Total assets Rs m10,38929,805 34.9%  
Interest coverage x43.13.5 1,241.9%   
Debt to equity ratio x00.3 0.7%  
Sales to assets ratio x0.60.5 119.3%   
Return on assets %8.78.9 98.0%  
Return on equity %10.511.8 88.8%  
Return on capital %19.517.5 111.3%  
Exports to sales %024.8 0.0%   
Imports to sales %03.7 0.0%   
Exports (fob) Rs mNA3,956 0.0%   
Imports (cif) Rs mNA596 0.0%   
Fx inflow Rs m5,6224,952 113.5%   
Fx outflow Rs m1,799697 258.2%   
Net fx Rs m3,8224,255 89.8%   
CASH FLOW
From Operations Rs m3562,786 12.8%  
From Investments Rs m-279-1,529 18.2%  
From Financial Activity Rs m-225-941 23.9%  
Net Cashflow Rs m-148316 -46.8%  

Share Holding

Indian Promoters % 63.4 61.4 103.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 3.7 -  
FIIs % 0.0 12.7 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 22.1 165.2%  
Shareholders   37,287 46,261 80.6%  
Pledged promoter(s) holding % 0.0 35.8 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE SCIENCES With:   PANACEA BIOTECH  AJANTA PHARMA  UNICHEM LAB  NATCO PHARMA  ELDER PHARMA  

Compare SUVEN LIFE SCIENCES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 154 Points Lower, Nifty Ends at 14,834; Bajaj Finance and UPL Among Top Losers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended marginally lower.

Related Views on News

SUVEN LIFESCIENCES Announces Quarterly Results (1QFY20); Net Profit Up 47.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 572 m (up 47.2% YoY). Sales on the other hand came in at Rs 2 bn (up 3.8% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

SUVEN LIFESCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 22, 2019 | Updated on Jul 22, 2019

Here's an analysis of the annual report of SUVEN LIFESCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFESCIENCES. Also includes updates on the valuation of SUVEN LIFESCIENCES.

SUVEN LIFESCIENCES Announces Quarterly Results (4QFY19); Net Profit Up 8.7% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 680 m (up 8.7% YoY). Sales on the other hand came in at Rs 3 bn (up 18.5% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

SUVEN LIFESCIENCES Announces Quarterly Results (1QFY20); Net Profit Up 47.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 572 m (up 47.2% YoY). Sales on the other hand came in at Rs 2 bn (up 3.8% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

SUVEN LIFESCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 22, 2019 | Updated on Jul 22, 2019

Here's an analysis of the annual report of SUVEN LIFESCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFESCIENCES. Also includes updates on the valuation of SUVEN LIFESCIENCES.

More Views on News

Most Popular

A Critical Update on the Market(Fast Profits Daily)

Mar 30, 2021

In this video, I'll tell you why I am recommending caution in the market at this time.

My Recent Recommendation Will Profit from the Global Supply Chain Crisis(Profit Hunter)

Mar 31, 2021

A tiny chemical company, started in the Licence Raj era, is a great example of a new wealth creating opportunity.

My Stock Trading Strategy(Fast Profits Daily)

Mar 31, 2021

In this video I'll show you exactly how I go about picking stocks for trading.

What You Need to Find Hundred Baggers(Profit Hunter)

Mar 30, 2021

100 baggers of the last decade share this common trait. Here's how to use it to nail future multibaggers.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFE SCIENCES SHARE PRICE


Apr 9, 2021 (Close)

TRACK SUVEN LIFE SCIENCES

  • Track your investment in SUVEN LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUVEN LIFE SCIENCES

SUVEN LIFE SCIENCES 5-YR ANALYSIS

COMPARE SUVEN LIFE SCIENCES WITH

MARKET STATS